Droperidol

BreastfeedingPediatric
  • TRADE NAMES: Dehydrobenzperidol; Droleptan; Droperidol; Inapsin; Inapsine (Akorn); Sintodian; Xomolix (ProStrakan)
  • INDICATIONS: Tranquilizer and antiemetic in surgical procedures
  • CLASS: Antiemetic, Antipsychotic, Butyrophenone
  • HALF-LIFE: 2.3 hours

Contra-indicated in patients with known or suspected QT prolongation.

This product is not available in the European market.

QT PROLONGATION AND TORSADE DE POINTES

See full prescribing information for complete boxed warning.

Our database has 23 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
OCULAR
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric